The FDA announced on March 24, 2014, that Apotex Inc. voluntarily recalled PAXIL CR (Paroxetine HCL) Controlled-Release Tablets 25 mg due to chemical contamination from residual materials and solvents in the active pharmaceutical ingredient batches.
How to tell if you have it
- Brand: Apotex
- Product: PAXIL CR (Paroxetine HCL) Controlled-Release Tablets 25 mg, 30-count bottle
- NDC: 60505-3669-3
- Lot #: 2F004
- Expiration Date: 06/15
- Manufacturer: GlaxoSmithKline, RTP, NC 27709
- Distributed nationwide and in Puerto Rico
The hazard
The product was manufactured with active pharmaceutical ingredient batches contaminated with residual materials and solvents. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show Apotex Inc. has had 19 other recalls on record since April 30, 2012. Other recent recalls of similar products include Apotex Metformin Tablets Recall regarding NDMA impurity risk (May 27, 2020), Apotex Atorvastatin 40mg Tablets Recall for foreign pravastatin presence (Oct. 22, 2019), and Apotex Rite Aid Maximum Strength Ranitidine Tablets Recall for possible NDMA contamination (Sept. 24, 2019). Additional recent recalls include Apotex Paxil CR 37.5mg Tablets Recall for failed stability testing (Aug. 13, 2026), Apotex Recalls Paroxetine 37.5mg due to dissolution failure (Sept. 23, 2026), and Apotex Desmopressin Nasal Spray Recall for defective bottle caps risk (April 8, 2026).